bioMérieux S.A./€BIM
05:30
03:10
00:45
22:25
20:00
1D1W1MYTD1Y5YMAX
About bioMérieux S.A.
bioMérieux S.A. is a French company specialized in the field of in vitro diagnostics, operating within the healthcare industry. The company develops, manufactures, and markets diagnostic solutions that are primarily used for detecting disease-causing microorganisms. These solutions include a broad range of products, such as diagnostic tests for infectious diseases, cancer, and cardiovascular diseases, as well as industrial microbiological controls. Founded in 1963 by Alain Mérieux, bioMérieux is headquartered in Marcy-l'Étoile, near Lyon, France. The company has a global presence, serving clients around the world through a network of subsidiaries and distributors. Its competitive strength lies in its extensive product portfolio and commitment to research and development, enabling it to address evolving medical and industrial testing needs.
Ticker
€BIM
Sector
Primary listing
PAR
Employees
14,451
Headquarters
Website
bioMérieux S.A. Metrics
BasicAdvanced
€15B
34.51
€3.64
0.53
€0.90
0.72%
Price and volume
Market cap
€15B
Beta
0.53
52-week high
€127.00
52-week low
€94.20
Average daily volume
102K
Dividend rate
€0.90
Financial strength
Current ratio
2.204
Quick ratio
1.223
Long term debt to equity
8.293
Total debt to equity
11.653
Dividend payout ratio (TTM)
23.18%
Interest coverage (TTM)
125.45%
Profitability
EBITDA (TTM)
948.2
Gross margin (TTM)
55.66%
Net profit margin (TTM)
10.86%
Operating margin (TTM)
15.45%
Effective tax rate (TTM)
26.63%
Revenue per employee (TTM)
€280,000
Management effectiveness
Return on assets (TTM)
7.23%
Return on equity (TTM)
10.68%
Valuation
Price to earnings (TTM)
34.505
Price to revenue (TTM)
3.717
Price to book
3.52
Price to tangible book (TTM)
4.96
Price to free cash flow (TTM)
46.007
Free cash flow yield (TTM)
2.17%
Free cash flow per share (TTM)
2.73
Dividend yield (TTM)
0.72%
Forward dividend yield
0.72%
Growth
Revenue change (TTM)
8.31%
Earnings per share change (TTM)
20.93%
3-year revenue growth (CAGR)
5.64%
10-year revenue growth (CAGR)
8.89%
3-year earnings per share growth (CAGR)
-10.40%
10-year earnings per share growth (CAGR)
12.31%
3-year dividend per share growth (CAGR)
1.92%
10-year dividend per share growth (CAGR)
10.44%
Bulls say / Bears say
bioMérieux reported a 9.10% year-over-year increase in revenue for Q4 2024, indicating strong financial performance. (Google Finance)
The company's net income rose by 10.66% in the same period, reflecting improved profitability. (Google Finance)
Analysts have set an average 12-month price target of €123.54 for bioMérieux, suggesting potential upside from current levels. (Investing.com)
bioMérieux experienced a 43.1% increase in short interest as of February 28, 2025, indicating growing bearish sentiment among investors. (Defense World)
The company's P/E ratio stands at 32.59, which may be considered high compared to industry peers, potentially limiting further stock appreciation. (StockAnalysis.com)
bioMérieux's dividend yield is relatively low at 0.76%, which might not attract income-focused investors. (StockAnalysis.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for bioMérieux S.A. stock?
bioMérieux S.A. (BIM) has a market cap of €15B as of August 05, 2025.
What is the P/E ratio for bioMérieux S.A. stock?
The price to earnings (P/E) ratio for bioMérieux S.A. (BIM) stock is 34.51 as of August 05, 2025.
Does bioMérieux S.A. stock pay dividends?
Yes, the bioMérieux S.A. (BIM) stock pays dividends to shareholders. As of August 05, 2025, the dividend rate is €0.9 and the yield is 0.72%. bioMérieux S.A. has a payout ratio of 23.18% on a trailing twelve-month basis.
When is the next bioMérieux S.A. dividend payment date?
The next bioMérieux S.A. (BIM) dividend payment date is unconfirmed.
What is the beta indicator for bioMérieux S.A.?
bioMérieux S.A. (BIM) has a beta rating of 0.53. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.